BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19899804)

  • 1. Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7.
    Sutherland JN; Maynard JA
    Biochemistry; 2009 Dec; 48(50):11982-93. PubMed ID: 19899804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.
    Sutherland JN; Chang C; Yoder SM; Rock MT; Maynard JA
    Clin Vaccine Immunol; 2011 Jun; 18(6):954-62. PubMed ID: 21508166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization.
    Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody that neutralizes pertussis toxin activities.
    Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping.
    Lang AB; Ganss MT; Cryz SJ
    Infect Immun; 1989 Sep; 57(9):2660-5. PubMed ID: 2474500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries.
    Felici F; Luzzago A; Folgori A; Cortese R
    Gene; 1993 Jun; 128(1):21-7. PubMed ID: 7685299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.
    Kim KJ; Burnette WN; Sublett RD; Manclark CR; Kenimer JG
    Infect Immun; 1989 Mar; 57(3):944-50. PubMed ID: 2465274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo.
    Wagner EK; Wang X; Bui A; Maynard JA
    Clin Vaccine Immunol; 2016 Nov; 23(11):851-862. PubMed ID: 27581436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of an Iranian
    Nikbin VS; Keramati M; Noofeli M; Tayebzadeh F; Kahali B; Shahcheraghi F
    J Med Microbiol; 2020 Jan; 69(1):111-119. PubMed ID: 31778110
    [No Abstract]   [Full Text] [Related]  

  • 11. Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking.
    Acquaye-Seedah E; Huang Y; Sutherland JN; DiVenere AM; Maynard JA
    Cell Microbiol; 2018 Dec; 20(12):e12948. PubMed ID: 30152075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
    Sato H; Ito A; Chiba J; Sato Y
    Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antibodies elicited by immunization with pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Gotto J
    Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of monoclonal antibody to pertussis toxin on toxin activity.
    Sato H; Sato Y; Ito A; Ohishi I
    Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis.
    Fiett J; Letowska I; Gniadkowski M; Hryniewicz W
    J Microbiol Methods; 2003 Dec; 55(3):651-66. PubMed ID: 14607408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.